Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers?
Aim of review. To present rational on expediency of Helicobacter pylori (H. pylori) eradication for erosions and ulcers that develop on the background of nonsteroid anti-inflammatory drugs (NSAIDs) therapy. Summary. According to the data of Maastricht consensus (2012), H. pylori infection and NSAIDs...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2018-08-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/91 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860315074330624 |
|---|---|
| author | A. Ye. Karateyev Ye. V. Moroz Anastasia V. Tsurgan N. V. Gontarenko |
| author_facet | A. Ye. Karateyev Ye. V. Moroz Anastasia V. Tsurgan N. V. Gontarenko |
| author_sort | A. Ye. Karateyev |
| collection | DOAJ |
| description | Aim of review. To present rational on expediency of Helicobacter pylori (H. pylori) eradication for erosions and ulcers that develop on the background of nonsteroid anti-inflammatory drugs (NSAIDs) therapy. Summary. According to the data of Maastricht consensus (2012), H. pylori infection and NSAIDs are the two major independent etiological factors of peptic ulcer development and upper gastro-intestinal bleeding. However the effect of H. pylori and NSAIDs on gastrointestinal diseases remains uncertain. This is a crucial question as the most of patients (in the Russian population over 50%), that require NSAIDs and low doses of aspirin (LDA) are infected by H. pylori. According to series of studies, H. pylori is significantly more common in patients with NSAID-related gastropathy. H. pylori eradication is capable to decrease the risk of gastrointestinal diseases if carried out prior to NSAIDs prescription. At the same time, severe complicated forms of gastrointestinal diseases are common in H. pylori-negative patients, and H. pylori eradication in patients with NSAID-associated ulcers or ulcer bleeding does not provide essential decrease in recurrence rate at ongoing NSAID intake. In the analysis of large-scale NSAID safety studies no significant difference in endoscopic ulcer rate in the groups of H. pylori-infected and H. pylori-negative patients were detected. Available data allow to conclude that anti-H. pylori therapy requires differential approach in patients with indications for NSAID and LDA treatment. Conclusion. Diagnostics of H. pylori infection and eradication is indicated at development of severe complications (ulcer, bleeding), however they should not be used in routine practice at treatment in patients with low risk of complications. Anyway, H. pylori eradication does not eliminate necessity of other methods for NSAID gastropathy prophylaxis: application of COX-2 selective inhibitors and PPI preventive prescription. |
| format | Article |
| id | doaj-art-e34619f9999747d1ad5e095e9d5d3a60 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2018-08-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-e34619f9999747d1ad5e095e9d5d3a602025-02-10T16:14:28ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-0126651710.22416/1382-4376-2016-6-5-1791Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers?A. Ye. Karateyev0Ye. V. Moroz1Anastasia V. Tsurgan2N. V. Gontarenko3Federal state government-financed scientific institution «Nasonova research institute of rheumatology»Federal state government institution «Burdenko main military clinical hospital»Federal state government-financed scientific institution «Nasonova research institute of rheumatology»Federal state government-financed scientific institution «Nasonova research institute of rheumatology»Aim of review. To present rational on expediency of Helicobacter pylori (H. pylori) eradication for erosions and ulcers that develop on the background of nonsteroid anti-inflammatory drugs (NSAIDs) therapy. Summary. According to the data of Maastricht consensus (2012), H. pylori infection and NSAIDs are the two major independent etiological factors of peptic ulcer development and upper gastro-intestinal bleeding. However the effect of H. pylori and NSAIDs on gastrointestinal diseases remains uncertain. This is a crucial question as the most of patients (in the Russian population over 50%), that require NSAIDs and low doses of aspirin (LDA) are infected by H. pylori. According to series of studies, H. pylori is significantly more common in patients with NSAID-related gastropathy. H. pylori eradication is capable to decrease the risk of gastrointestinal diseases if carried out prior to NSAIDs prescription. At the same time, severe complicated forms of gastrointestinal diseases are common in H. pylori-negative patients, and H. pylori eradication in patients with NSAID-associated ulcers or ulcer bleeding does not provide essential decrease in recurrence rate at ongoing NSAID intake. In the analysis of large-scale NSAID safety studies no significant difference in endoscopic ulcer rate in the groups of H. pylori-infected and H. pylori-negative patients were detected. Available data allow to conclude that anti-H. pylori therapy requires differential approach in patients with indications for NSAID and LDA treatment. Conclusion. Diagnostics of H. pylori infection and eradication is indicated at development of severe complications (ulcer, bleeding), however they should not be used in routine practice at treatment in patients with low risk of complications. Anyway, H. pylori eradication does not eliminate necessity of other methods for NSAID gastropathy prophylaxis: application of COX-2 selective inhibitors and PPI preventive prescription.https://www.gastro-j.ru/jour/article/view/91нестероидные противовоспали-тельные препаратынизкие дозы аспиринанпвп-гастропатияязвакровотечениепрофилактикаhelicobacter pyloriэрадикация |
| spellingShingle | A. Ye. Karateyev Ye. V. Moroz Anastasia V. Tsurgan N. V. Gontarenko Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers? Российский журнал гастроэнтерологии, гепатологии, колопроктологии нестероидные противовоспали-тельные препараты низкие дозы аспирина нпвп-гастропатия язва кровотечение профилактика helicobacter pylori эрадикация |
| title | Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers? |
| title_full | Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers? |
| title_fullStr | Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers? |
| title_full_unstemmed | Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers? |
| title_short | Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers? |
| title_sort | is helicobacter pylori eradication required for non steroidal anti inflammatory drug associated erosions and ulcers |
| topic | нестероидные противовоспали-тельные препараты низкие дозы аспирина нпвп-гастропатия язва кровотечение профилактика helicobacter pylori эрадикация |
| url | https://www.gastro-j.ru/jour/article/view/91 |
| work_keys_str_mv | AT ayekarateyev ishelicobacterpylorieradicationrequiredfornonsteroidalantiinflammatorydrugassociatederosionsandulcers AT yevmoroz ishelicobacterpylorieradicationrequiredfornonsteroidalantiinflammatorydrugassociatederosionsandulcers AT anastasiavtsurgan ishelicobacterpylorieradicationrequiredfornonsteroidalantiinflammatorydrugassociatederosionsandulcers AT nvgontarenko ishelicobacterpylorieradicationrequiredfornonsteroidalantiinflammatorydrugassociatederosionsandulcers |